1. Muniswami, D. M., Kanthakumar, P., Kanakasabapathy, I. & Tarion, G. Motor recovery afer transplantation of bone marrow mesenchymal stem cells in rat models of spinal cord injury. Ann. Neurosci. 25, 126–140 (2019).
2. Pittenger, M. F. et al. Multilineage potential of adult human mesenchymal stem cells. Science 284, 143–147 (1999).
3. Zuk, P. A. et al. Human adipose tissue is a source of multipotent stem cells. Mol. Biol. Cell. 13, 4279–4295 (2002).
4. Kisiel, A. H. et al. Isolation, characterization, and in vitro proliferation of canine mesenchymal stem cells derived from bone marrow, adipose tissue, muscle, and periosteum. Am. J. Vet. Res. 73, 1305–1317 (2012).
5. Reich, C. M. et al. Isolation, culture and chondrogenic diferentiation of canine adipose tissue- and bone marrow-derived mesenchymal stem cells: A comparative study. Vet. Res. Commun. 36, 139–148 (2012).
6. Melief, S. M., Jan Zwaginga, J., Fibbe, W. E. & Roelofs, H. Adipose tissue-derived multipotent stromal cells have a higher immunomodulatory capacity than their bone marrow-derived counterparts. Stem Cells Transl. Med. 2, 455–463 (2013).
7. Abiko, M. et al. Rat cranial bone-derived mesenchymal stem cell transplantation promotes functional recovery in ischemic stroke model rats. Stem Cells Dev. 27, 1053–1061 (2018).
8. Oshita, J. et al. Early transplantation of human cranial bone-derived mesenchymal stem cells enhances functional recovery in ischemic stroke model rats. Neurol. Med. Chir. 60, 83–93 (2020).
9. Shinagawa, K. et al. Te characteristics of human cranial bone marrow mesenchymal stem cells. Neurosci. Lett. 606, 161–166 (2015).
10. Yuyo, M. et al. A novel bone-thinning technique for transcranial stimulation motor-evoked potentials in rats. Sci. Rep. 11, 11 (2021).
11. Kjell, J. & Olson, L. Rat models of spinal cord injury: From pathology to potential therapies. Dis. Models Mech. 9, 1125–1137 (2016).
12. Iyer, S., Maybhate, A., Presacco, A. & All, A. H. Multi-limb acquisition of motor evoked potentials and its application in spinal cord injury. J. Neurosci. Met. 193, 210–216 (2010).
13. Redondo-Castro, E., Navarro, X. & García-Alías, G. Longitudinal evaluation of residual cortical and subcortical motor evoked potentials in spinal cord injured rats. J. Neurotrauma 33, 907–916 (2016).
14. Luf, A. R. et al. Transcranial magnetic stimulation in the rat. Exp. Brain Res. 140, 112–121 (2001).
15. Xie, C., Li, X., Fang, L. & Wang, T. Efects of athermal shortwave diathermy treatment on somatosensory evoked potentials and motor evoked potentials in rats with spinal cord injury. Spine 44, E749–E758 (2019).
16. Xing, J., Katayama, Y., Yamamoto, T., Hirayama, T. & Tsubokawa, T. Quantitative evaluation of hemiparesis with corticomyographic motor evoked potential recorded by transcranial magnetic stimulation. J. Neurotrauma 7, 57–64 (1990).
17. Tatsuya, S. et al. Avoidance of cerebral infarction in the territory of perforating arteries using intraoperative motor evoked potential in aneurysm surgery: Current status and limitation. Surg. Cereb. Stroke 42, 347–352 (2014).
18. Tanaka, S., Tashiro, T., Gomi, A., Takanashi, J. & Ujjie, H. Sensitivity and specifcity in transcranial motor-evoked potential monitoring during neurosurgical operations. Surg. Neurol. Int. 2, 111 (2011).
19. Murphy, P. G., Grondin, J., Altares, M. & Richardson, P. M. Induction of interleukin-6 in axotomized sensory neurons. J. Neurosci. 15, 5130–5138 (1995).
20. Gurcan, O. et al. Efect of asiatic acid on the treatment of spinal cord injury: An experimental study in rats. Turk. Neurosurg. 27, 259–264 (2017).
21. Imura, T. et al. Hypoxic preconditioning increases the neuroprotective efects of mesenchymal stem cells in a rat model of spinal cord injury. J. Stem Cell Res. Ter. 7, 1 (2017).
22. Donnelly, D. J. & Popovich, P. G. Infammation and its role in neuroprotection, axonal regeneration and functional recovery afer spinal cord injury. Exp. Neurol. 209, 378–388 (2008).
23. Sharma, H. S. et al. Topical application of TNF-alpha antiserum attenuates spinal cord trauma induced edema formation, microvascular permeability disturbances and cell injury in the rat. Acta Neurochir. Suppl. 86, 407–413 (2003).
24. Degterev, A. et al. Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury. Nat. Chem. Biol. 1, 112–119 (2005).
25. Lu, J. V., Chen, H. C. & Walsh, C. M. Necroptotic signaling in adaptive and innate immunity. Semin. Cell Dev. Biol. 35, 33–39 (2014).
26. Fan, H. et al. Reactive astrocytes undergo M1 microglia/macrophages-induced necroptosis in spinal cord injury. Mol. Neurodegener. 11, 14 (2016).
27. Albayrak, Ö. et al. Mesenchymal stem cell therapy improves erectile dysfunction in experimental spinal cord injury. Int. J. Impot. Res. 32, 308–316 (2020).
28. Wang, L. et al. Mesenchymal stem cell-derived exosomes reduce A1 astrocytes via downregulation of phosphorylated NFκB P65 subunit in spinal cord injury. Cell Physiol. Biochem. 50, 1535–1559 (2018).
29. Mothe, A. J. & Tator, C. H. Advances in stem cell therapy for spinal cord injury. J. Clin. Invest. 122, 3824–3834 (2012).
30. Orzalli, M. H. & Kagan, J. C. Apoptosis and necroptosis as host defense strategies to prevent viral infection. Trends Cell Biol. 27, 800–809 (2017).
31. Weinlich, R., Oberst, A., Beere, H. M. & Green, D. R. Necroptosis in development, infammation and disease. Nat. Rev. Mol. Cell Biol. 18, 127–136 (2017).
32. Hsu, H., Huang, J., Shu, H. B., Baichwal, V. & Goeddel, D. V. TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex. Immunity 4, 387–396 (1996).
33. Tornton, C. & Hagberg, H. Role of mitochondria in apoptotic and necroptotic cell death in the developing brain. Clin. Chim. Acta 7, 35–38 (2015).
34. Micheau, O. & Tschopp, J. Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 114, 181–190 (2003).
35. Li, S. J. et al. Te role of TNF-alpha, IL-6, IL-10, and GDNF in neuronal apoptosis in neonatal rat with hypoxic-ischemic encephalopathy. Eur. Rev. Med. Pharmacol. Sci. 18, 905–909 (2014).
36. Morrice, J. R., Gregory-Evans, C. Y. & Shaw, C. A. Necroptosis in amyotrophic lateral sclerosis and other neurological disorders. Biochim. Biophys. Acta Mol. Basis Dis. 1863, 347–353 (2017).
37. Chen, S. D., Wu, C. L., Hwang, W. C. & Yang, D. I. More Insight into BDNF against neurodegeneration: Anti-apoptosis, antioxidation, and suppression of autophagy. Int. J. Mol. Sci. 18, 545 (2017).
38. Ying, X. et al. Hyperbaric oxygen therapy reduces apoptosis and dendritic/synaptic degeneration via the BDNF/TrkB signaling pathways in SCI rats. Life Sci. 229, 187–199 (2019).
39. Jiang, Y. L., Liu, W. W., Wang, Y. & Yang, W. Y. MiR-210 suppresses neuronal apoptosis in rats with cerebral infarction through regulating VEGF-notch signaling pathway. Eur. Rev. Med. Pharmacol. Sci. 24, 4971–4918 (2020).
40. Su, R., Su, W. & Jiao, Q. NGF protects neuroblastoma cells against beta-amyloid-induced apoptosis via the Nrf2/HO-1 pathway. FEBS Open Bio 9, 2063–2071 (2019).
41. Montero, M. L. et al. Docosahexaenoic acid protection against palmitic acid-induced lipotoxicity in NGF-diferentiated PC12 cells involves enhancement of autophagy and inhibition of apoptosis and necroptosis. J. Neurochem. 155, 559–576 (2020).
42. Saeidikhoo, S. et al. Efect of Sertoli cell transplantation on reducing neuroinfammation-induced necroptosis and improving motor coordination in the rat model of cerebellar ataxia induced by 3-acetylpyridine. J. Mol. Neurosci. 70, 1153–1163 (2020).
43. Otsuka, T. et al. Comparisons of neurotrophic efects of mesenchymal stem cells derived from diferent tissue on chronic spinal cord injury rats. Stem Cells Dev. 30, 865–875 (2021).
44. Pomies, P. et al. Involvement of the FoxO1/MuRF1/Atrogin-1 signaling pathway in the oxidative stress-induced atrophy of cultured chronic obstructive pulmonary disease myotubes. PLoS ONE 11, e0160092 (2016).
45. Gutierrez-Fernandez, M. et al. Efects of intravenous administration of allogenic bone marrow- and adipose tissue-derived mesenchymal stem cells on functional recovery and brain repair markers in experimental ischemic stroke. Stem Cell Res. Ter. 4, 11 (2013).
46. Mitsuhara, T. et al. Simulated microgravity facilitates cell migration and neuroprotection afer bone marrow stromal cell transplantation in spinal cord injury. Stem Cell Res. Ter. 4, 35 (2013).
47. Basso, D. M., Beattie, M. S. & Bresnahan, J. C. Graded histological and locomotor outcomes afer spinal cord contusion using the NYU weight-drop device versus transection. Exp. Neurol. 139, 244–256 (1996).
48. Sakai, K. et al. Human dental pulp-derived stem cells promote locomotor recovery afer complete transection of the rat spinal cord by multiple neuro-regenerative mechanisms. J. Clin. Invest. 122, 80–90 (2012).
49. Basso, D. M., Beattie, M. S. & Bresnahan, J. C. A sensitive and reliable locomotor rating scale for open feld testing in rats. J. Neurotrauma 12, 1–21 (1995).
50. Wells, J. E. et al. An adverse role for matrix metalloproteinase 12 afer spinal cord injury in mice. J. Neurosci. 23, 10107–10115 (2003).
51. Rivlin, A. S. & Tator, C. H. Objective clinical assessment of motor function afer experimental spinal cord injury in the rat. J. Neurosurg. 47, 577–581 (1977).
52. Sekine, Y. et al. Te Kelch repeat protein KLHDC10 regulates oxidative stress-induced ASK1 activation by suppressing PP5. Mol. Cell. 48, 692–704 (2012).
53. Neirinckx, V. et al. Adult bone marrow mesenchymal and neural crest stem cells are chemoattractive and accelerate motor recovery in a mouse model of spinal cord injury. Stem Cell Res. Ter. 6, 211 (2015).